Acute myocardial infarction is the result of an acute interruption of
myocardial blood flow resulting in ischemic myocardial necrosis. The p
athogenesis of this phenomenon nearly always involves acute thrombosis
superimposed on a disrupted atherosclerotic plaque. Thrombolytic agen
ts have been conclusively shown to reduce mortality in many patient su
bgroups with myocardial infarction, including the elderly, patients wi
th inferior myocardial infarction, and patients with systolic hyperten
sion. Nearly all patients with acute myocardial infarction of less tha
n 6 h in duration with S-T segment elevation should receive thrombolys
is unless significant contraindications exist and outweigh the potenti
al benefits. Aspirin should be given to almost all patients regardless
of whether they receive thrombolysis. Angioplasty and coronary artery
bypass surgery are useful as primary or secondary modes of reperfusio
n in selected patients with infarction.